A detailed history of Cibc Asset Management Inc transactions in Geron Corp stock. As of the latest transaction made, Cibc Asset Management Inc holds 15,799 shares of GERN stock, worth $59,562. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,799
Previous 15,438 2.34%
Holding current value
$59,562
Previous $65,000 9.23%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$4.17 - $4.99 $1,505 - $1,801
361 Added 2.34%
15,799 $71,000
Q2 2024

Aug 01, 2024

BUY
$3.1 - $5.09 $11,795 - $19,367
3,805 Added 32.71%
15,438 $65,000
Q1 2023

May 12, 2023

BUY
$2.14 - $3.4 $977 - $1,553
457 Added 4.09%
11,633 $25,000
Q4 2022

Feb 13, 2023

BUY
$2.03 - $2.42 $22,687 - $27,045
11,176 New
11,176 $27,000
Q3 2021

Nov 09, 2021

SELL
$1.2 - $1.5 $14,613 - $18,267
-12,178 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$1.52 - $2.1 $18,510 - $25,573
12,178 New
12,178 $19,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.42B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Cibc Asset Management Inc Portfolio

Follow Cibc Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.